Ordinary Index Rebalancing in the Solactive Pharma & Biotech Opportunity Index | May 2020

In the ordinary rebalance the following composition will be implemented:

3SBIO INC
AGIOS PHARMACEUTICALS INC
ALKERMES PLC
AMARIN CORPORATION PLC -ADR
BIOMARIN PHARMACEUTICAL INC
BLUEBIRD BIO INC
BLUEPRINT MEDICINES CORP
CHINA BIOLOGIC PRODUCTS HOLD
CHINA MEDICAL SYSTEM HOLDINGS LTD
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO LTD
CSPC PHARMACEUTICAL GROUP LTD
EMERGENT BIOSOLUTIONS INC
EXELIXIS INC
GALAPAGOS NV
HANMI PHARM CO LTD
HORIZON THERAPEUTICS PLC
IONIS PHARMACEUTICALS INC
IPSEN SA
JAZZ PHARMACEUTICALS PLC
NEKTAR THERAPEUTICS
NIPPON SHINYAKU CO LTD
ONO PHARMACEUTICAL CO LTD ORD
RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT.
SANTEN PHARMACEUTICAL CO LTD ORD
SAWAI PHARMACEUTICAL CO LTD ORD
SINO BIOPHARMACEUTICAL LTD ORD
SUMITOMO DAINIPPON PHARMA CO ORD
SWEDISH ORPHAN BIOVITRUM AB
UCB SA
VIFOR PHARMA AG